A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection
Sign Up to like & getrecommendations! Published in 2017 at "Pharmacoeconomics"
DOI: 10.1007/s40273-017-0540-2
Abstract: Background and ObjectiveClostridium difficile infection (CDI) is associated with high management costs, particularly in recurrent cases. Fidaxomicin treatment results in lower recurrence rates than vancomycin and metronidazole, but has higher acquisition costs in Europe and… read more here.
Keywords: cdi; difficile infection; cost effective; effective versus ... See more keywords